Trials / Completed
CompletedNCT00027079
Combined Pharmacotherapies for Alcoholism (Naltrexone/Ondansetron)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 360 (planned)
- Sponsor
- National Institute on Alcohol Abuse and Alcoholism (NIAAA) · NIH
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study will compare the effectiveness of ondansetron (Zofran) and naltrexone (ReVia) both alone and in combination in treating Early Onset Alcoholics versus Late Onset Alcoholics. All subjects will received standardized Cognitive Behavioral Therapy. Followup assessments will be completed at 1, 3, 6, and 9 months after treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ondansetron (Zofran) | |
| DRUG | naltrexone (ReVia) | |
| BEHAVIORAL | Cognitive Behavioral Therapy |
Timeline
- Start date
- 2001-09-01
- Completion
- 2004-08-01
- First posted
- 2001-11-21
- Last updated
- 2007-12-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00027079. Inclusion in this directory is not an endorsement.